Loading patent…
AssigneeJanssen Pharmaceutica NV
InventorsSteven D. Goldberg, Douglas C. Behenna, Deane Gordon, Luke E. Hanna, Steven A. Loskot, Stefan McCarver, Steven P. Meduna, Brock T. Shireman, Alexander E. Valdes, Jennifer D. Venable, Dongpei Wu
Estimating the term…
The present application discloses compounds having the following formula: or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
A compound or a pharmaceutically acceptable salt thereof, having a formula selected from the group consisting of:
A compound or a pharmaceutically acceptable salt thereof, having a formula selected from the group consisting of:
A compound or a pharmaceutically acceptable salt thereof, having a formula selected from the group consisting of:
Dependencies are inferred from the claim text.